BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14737076)

  • 1. Abundant expression of fibronectin is a major feature of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
    Vialle-Castellano A; Gaugler B; Mohty M; Isnardon D; van Baren N; Olive D
    Leukemia; 2004 Mar; 18(3):426-33. PubMed ID: 14737076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Li L; Schmitt A; Reinhardt P; Greiner J; Ringhoffer M; Vaida B; Bommer M; Vollmer M; Wiesneth M; Döhner H; Schmitt M
    Cancer Immun; 2003 Jul; 3():8. PubMed ID: 12862419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
    Köhler T; Plettig R; Wetzstein W; Schmitz M; Ritter M; Mohr B; Schaekel U; Ehninger G; Bornhäuser M
    Stem Cells; 2000; 18(2):139-47. PubMed ID: 10742386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells.
    Curti A; Pandolfi S; Aluigi M; Isidori A; Alessandrini I; Chiodoni C; Testoni N; Colombo MP; Baccarani M; Lemoli RM
    Exp Hematol; 2005 Dec; 33(12):1521-30. PubMed ID: 16338495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia.
    Mohty M; Isnardon D; Blaise D; Mozziconacci MJ; Lafage-Pochitaloff M; Brière F; Gastaut JA; Olive D; Gaugler B
    Leukemia; 2002 Nov; 16(11):2267-74. PubMed ID: 12399972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biological characteristics of dendritic cells derived in vitro from myelogeneous leukemia cells and healthy donor cells.
    Tong XM; Yao HP; Qian WB; Zhu LF; Fu ZH; Huang ZL; Jin J
    Int J Lab Hematol; 2008 Oct; 30(5):372-81. PubMed ID: 18205840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
    Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
    J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion capacity and integrin expression by dendritic-like cells generated from acute myeloid leukemia blasts by calcium ionophore treatment.
    Sadovnikova E; Parovichnikova EN; Semikina EL; Kopiltsova EA; Svinareva DA; Belkin VM; Torubarova NA; Savchenko VG
    Exp Hematol; 2004 Jun; 32(6):563-70. PubMed ID: 15183897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells.
    Tsuchiya T; Hagihara M; Shimakura Y; Ueda Y; Gansuvd B; Munkhbat B; Inoue H; Tazume K; Kato S; Hotta T
    Int J Hematol; 2002 Jan; 75(1):55-62. PubMed ID: 11843292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blasts.
    Li L; Giannopoulos K; Reinhardt P; Tabarkiewicz J; Schmitt A; Greiner J; Rolinski J; Hus I; Dmoszynska A; Wiesneth M; Schmitt M
    Int J Oncol; 2006 Apr; 28(4):855-61. PubMed ID: 16525634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
    Draube A; Beyer M; Wolf J
    Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
    Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
    J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML.
    Gandini D; De Angeli C; Aguiari G; Manzati E; Lanza F; Pandolfi PP; Cuneo A; Castoldi GL; del Senno L
    Leukemia; 2002 May; 16(5):886-93. PubMed ID: 11986951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia.
    Nourizadeh M; Masoumi F; Memarian A; Alimoghaddam K; Moazzeni SM; Hadjati J
    Leuk Res; 2012 Sep; 36(9):1193-9. PubMed ID: 22579107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The T cells activated by dendritic cells derived from AML cells: a study of their cytotoxic effect on autologous AML cells].
    Xiang B; Li SF; Zhou J; Mao YQ; Yang YM; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):784-7. PubMed ID: 15573754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
    Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
    Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.